Sign in

NCT03479580Recruiting

Coronary Artery Disease and Coronary Microvascular Disease in Cardiomyopathies Registry

Source: ClinicalTrials.gov · Last updated 19 May 2022 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Long-term prognostic value of macrovascular and microvascular coronary artery stenoses in each type of cardiomyopathy.

Status (registry)
Recruiting
Study type
Observational
Enrollment
1600 (estimated)
First submitted
23 Jan 2018
Start date
8 Feb 2018
Primary completion date
29 Feb 2028
Lead sponsor
University Hospital, Grenoble
NCT number
NCT03479580

What you commit to

  • Study type: Observational
  • Planned participants: 1600
  • From 8 Feb 2018 to the primary completion date, 29 Feb 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Pregnant women
  • Breastfeeding women
  • Patients under legal protection

Who the study is looking for

  • Ischemic
  • Dilated
  • Hypertrophic
  • Restrictive cardiomyopathy.

Age in the registry: 18 years to 100 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Hospital Grenoble
Coordinator of this site? Confirm its status
La TroncheFranceRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.